Katarzyna Pancer

PhD/ass.prof

National Institute of Public Health - National Institute of Hygiene

Poland

Research Interests

Explore related searches

Professors in Poland Professors in Immunology Immunology professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Katarzyna Pancer is an Assistant Professor at the National Institute of Public Health - National Institute of Hygiene in Poland. Her research areas include infectious diseases, epidemiology, and cancer therapy. Recent publications highlight her work on Zika virus infections, Lyme disease incidence, and the immune evaluation of adenoviral vectors. Dr. Pancer is also involved in the study of bacterial communities in plumbing systems and their implications for public health.

Articles (16)

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (6)

Wojciech Branicki

Jagiellonian University

POLAND

View details

Magdalena Wieczorek

National Institute of Public Health - National Institute of Hygiene

POLAND

View details

Monika Staniszewska

University of Warsaw

POLAND

View details

Mariangela Garofalo

Assistant Professor (RTD B)

University of Padua

ITALY

View details

Lukasz Kuryk

Assistant Professor

National Institute of Public Health NIH - National Research Institute

POLAND

View details

Beate Rinner

Medical University of Graz

AUSTRIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Katarzyna Pancer

Research Interests

Explore related searches

Contact this professor

About

Articles (16)

First documented case of Zika virus infection in a Polish patient – diagnostic traps. Case report

Tick-borne encephalitis epidemiology and surveillance in Poland, and comparison with selected European countries before and during the COVID-19 pandemic, 2008 to 2020

Comparative study between virus neutralisation testing and other serological methods detecting anti-SARS-CoV-2 antibodies in Europe, 2021

Novel combinatorial therapy of oncolytic adenovirus AdV5/3-D24-ICOSL-CD40L with anti PD-1 exhibits enhanced anti-cancer efficacy through promotion of intratumoral T-cell infiltration and modulation of tumour microenvironment in mesothelioma mouse model

Estimated Incidence of Symptomatic Lyme Borreliosis Cases in Lublin, Poland in 2021

Premise plumbing bacterial communities in four European cities and their association with Legionella

In vitro immune evaluation of adenoviral vector-based platform for infectious diseases

Bacterial communities of premise plumbing systems in four European cities, and their association with culturable<italic> Legionella</italic>

From Immunosuppression to Immunomodulation-Turning Cold Tumours into Hot

Novel Insights Into Mesothelioma Therapy: Emerging Avenues and Future Prospects

Combination Therapy of Novel Oncolytic Adenovirus with Anti-PD1 Resulted in Enhanced Anti-Cancer Effect in Syngeneic Immunocompetent Melanoma Mouse Model

Combination Therapy of Novel Oncolytic Adenovirus with Anti-PD1 Resulted in Enhanced Anti-Cancer Effect in Syngeneic Immunocompetent Melanoma Mouse Model

Molekularna diagnostyka COVID-19 - dotychczasowe doświadczenia

From Conventional Therapies to Immunotherapy: Melanoma Treatment in Review

The SARS-CoV-2 ORF10 is not essential in vitro or in vivo in humans

The SARS-CoV-2 ORF10 is not essential in vitro or in vivo in humans

Collaborators (6)

Wojciech Branicki

Magdalena Wieczorek

Monika Staniszewska

Mariangela Garofalo

Lukasz Kuryk

Beate Rinner

Make your next move.